Two different STAT1 gain-of-function mutations lead to diverse IFN-γ-mediated gene expression

被引:13
|
作者
Ovadia, Adi [1 ,2 ,3 ,4 ]
Sharfe, Nigel [1 ,2 ,3 ,4 ]
Hawkins, Cynthia [5 ]
Laughlin, Suzanne [6 ]
Roifman, Chaim M. [1 ,2 ,3 ,4 ]
机构
[1] Hosp Sick Children, Dept Paediat, Div Immunol & Allergy, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Hosp Sick Children, Canadian Ctr Primary Immunodeficiency, Toronto, ON, Canada
[4] Hosp Sick Children, Jeffrey Modell Res Lab Diag Primary Immunodeficie, Toronto, ON, Canada
[5] Hosp Sick Children, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[6] Hosp Sick Children, Dept Radiol, Toronto, ON, Canada
来源
NPJ GENOMIC MEDICINE | 2018年 / 3卷
关键词
UNDERLIE;
D O I
10.1038/s41525-018-0063-6
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Signal transducer and activator of transcription 1 (STAT1) regulates multiple biological processes downstream of a variety of cytokine receptors in many cell types. Heterozygous gain-of-function (GOF) mutations in STAT1 have been associated with a diverse phenotype encompassing chronic mucocutaneous candidiasis (CMCC) and declining immunity. There is no dear correlation between STAT1 domain-specific mutations and phenotype, and it remains unclear why GOF mutations in STAT1 result in such a wide spectrum of clinical presentations. To begin exploring this dilemma, we have studied the patterns of gene expression mediated by two different GOF mutations. Analysis of IFN-gamma response elements using RNA microarrays in cells transfected with the rare H629Y mutant or the common R274G mutant showed distinct patterns of gene expression. We show here that the impact of GOF mutations in STAT1 is variant-specific. This difference in gene expression may explain the diversity in clinical manifestations experienced by these patients.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Gain-of-function mutations in STAT1: A new molecular cause for patients with chronic mucocutaneous candidiasis
    Depner, M.
    Wanders, J.
    Stauss, H.
    Jansson, A.
    Dueckers, G.
    Niehues, T.
    Baumann, U.
    Pedersen, A. Stray
    Kilic, S. S.
    Atkinson, T. P.
    Puck, J. M.
    Franco, J. L.
    Devlin, L.
    Jensen, T. D.
    Henderson, P.
    Matthijs, G.
    Ben Shoshan, M.
    McCusker, C.
    Jacob, C. M.
    Grimbacher, B.
    MYCOSES, 2012, 55 : 319 - 319
  • [42] RUXOLITINIB EFFECTS ON STAT1 GAIN OF FUNCTION MUTATIONS
    Zimmerman, Ofer
    Rosen, Lindsey B.
    Hsu, Amy P.
    Sampaio, Elizabeth P.
    Rosenzweig, Sergio D.
    Zerbe, Christa S.
    Holland, Steven M.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2015, 35 (03) : 327 - 327
  • [43] Increased STAT1 Amounts Correlate with the Phospho-STAT1 Level in STAT1 Gain-of-function Defects
    Bernasconi, Andrea R.
    Yancoski, Judith
    Villa, Mariana
    Oleastro, Matias M.
    Galicchio, Miguel
    Rossi, Jorge G.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2018, 38 (07) : 745 - 747
  • [44] Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC)
    Zheng, Jie
    de Veerdonk, Frank L. van
    Crossland, Katherine L.
    Smeekens, Sanne P.
    Chan, Chun M.
    Al Shehri, Tariq
    Abinun, Mario
    Gennery, Andrew R.
    Mann, Jelena
    Lendrem, Dennis W.
    Netea, Mihai G.
    Rowan, Andrew D.
    Lilic, Desa
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2015, 45 (10) : 2834 - 2846
  • [45] STAT1 Gain-of-Function Leading to Clinical Behcet's Syndrome
    Aluri, Jahnavi
    Schmitt, Erica
    Du, Matthew A.
    Cooper, Megan
    JOURNAL OF CLINICAL IMMUNOLOGY, 2023, 43 (06) : 1155 - 1158
  • [46] Novel STAT1 Gain-of-Function Mutation Presenting as Combined Immunodeficiency
    Stella P. Hartono
    Alexander Vargas-Hernández
    Mark J. Ponsford
    Ivan K. Chinn
    Stephen Jolles
    Keith Wilson
    Lisa R. Forbes
    Journal of Clinical Immunology, 2018, 38 : 753 - 756
  • [47] Proof-of-concept for a one-step gene therapy for STAT1 gain-of-function
    Iglesias-Herrero, C.
    Kristoforus, T.
    Schrijvers, R.
    Gijsbers, R.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A178 - A178
  • [48] Immunophenotyping and Therapeutic Insights from Chronic Mucocutaneous Candidiasis Cases with STAT1 Gain-of-Function Mutations
    Lei, Wei-Te
    Lo, Yu-Fang
    Tsumura, Miyuki
    Ding, Jing-Ya
    Lo, Chia-Chi
    Lin, You-Ning
    Wang, Chuang-Wei
    Liu, Lu-Hang
    Shih, Han-Po
    Peng, Jhan-Jie
    Wu, Tsai-Yi
    Chan, Yu-Pei
    Kang, Chen-Xuan
    Wang, Shang-Yu
    Kuo, Chen-Yen
    Tu, Kun-Hua
    Yeh, Chun-Fu
    Hsieh, Ya-Ju
    Asano, Takaki
    Chung, Wen-Hung
    Okada, Satoshi
    Ku, Cheng-Lung
    JOURNAL OF CLINICAL IMMUNOLOGY, 2024, 44 (08)
  • [49] Novel STAT1 Gain-of-Function Mutation Presenting as Combined Immunodeficiency
    Hartono, Stella P.
    Vargas-Hernandez, Alexander
    Ponsford, Mark J.
    Chinn, Ivan K.
    Jolles, Stephen
    Wilson, Keith
    Forbes, Lisa R.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2018, 38 (07) : 753 - 756
  • [50] Immunoprofiling of monocytes in STAT1 gain-of-function chronic mucocutaneous candidiasis
    Bloomfield, Marketa
    Zentsova, Irena
    Milota, Tomas
    Sediva, Anna
    Parackova, Zuzana
    FRONTIERS IN IMMUNOLOGY, 2022, 13